T1	Participants 50 96	blood pressure control and target organ damage
T2	Participants 167 188	hypertensive patients
T3	Participants 301 385	cardiovascular target organ damage and metabolic profile in 520 hypertensive patient
T4	Participants 1259 1280	hypertensive patients
